1-1 of 1
Authors: Martin Sprinzl
Journal Article
Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS Study Open Access
Open Forum Infectious Diseases, Volume 7, Issue 9, September 2020, ofaa356, https://doi.org/10.1093/ofid/ofaa356
Published: 13 August 2020
